Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69K Sell
8
-3
-27% -$643 ﹤0.01% 1084
2026
Q1
$2.43K Buy
11
+7
+175% +$1.71K ﹤0.01% 880
2025
Q4
$1.01K Sell
4
-4
-50% -$1K ﹤0.01% 1059
2025
Q3
$1.98K Buy
+8
New +$1.92K ﹤0.01% 661

Other funds holding STE

Kilter Group's STE Position: Q2 2026 in Review

Kilter Group reduced its Steris (STE) stake by 27% in Q2 2026, selling an estimated $643 and leaving 8 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1084.

Kilter Group first reported a position in STE in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.43K in Q1 2026. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Kilter Group held 8 shares of Steris worth $1.69K as of Q2 2026.
  • Kilter Group sold 3 Steris shares in Q2 2026, an estimated $643.
  • Steris made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #1084 holding.
  • Kilter Group first reported a position in Steris in Q3 2025 and has held it in 4 quarters since.
  • Kilter Group's Steris position peaked at $2.43K in Q1 2026.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.